Access to insulin and diabetes care in the Philippines
- PMID: 34826392
- DOI: 10.1016/S2213-8587(21)00309-0
Access to insulin and diabetes care in the Philippines
Conflict of interest statement
CAJ has received honoraria for serving on the speaker's bureau for Novo Nordisk, Sanofi Aventis, Merck, Merck, Sharpe and Dohme, Servier Philippines, and Johnson and Johnson. CAJ has also received support for attending meetings and travel for conventions from Sanofi Aventis, Merck, Sharpe and Dohme, Natrapharm, Novo Nordisk and AstraZeneca. All other authors declare no competing interests.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
